---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "7m8TCgEZiVcxTVwBUQ8+Vjwqln9QKJ8+Y4bD04iFfn+OItNO9lwMXKVR1/7gvMIVmzeNBNu8OPnxI/LbxY7YwfVHjAjxQiwn/TpyMS/qigskWB1+xGdSEddQyp8MfYlgOMaCCCcnx4IsB3Ro5coclLk4QH4aApZvxZnIFbI3nAXXkWkY8Z32VP19YI8WaiD+ww9nK1k2jeJpfcUYRmbtSyMNNKirQdj1ST8Yl0Dcx3x04jQbafK0JivCx4+m6x6d9gKlWBsDYgzpls83wtdP5IA+TN/pHZ3TWClK0Mxga5b8XFLpdcbqkgh8SFQLNYV1;Cdgyxv1lGpigz4sLQoh9dg=="
---

